Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Receivables (2023 - 2025)

Upstream Bio has reported Change in Receivables over the past 3 years, most recently at -$15000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$15000.0 for Q4 2025, down 350.0% from a year ago — trailing twelve months through Dec 2025 was $55000.0 (down 89.32% YoY), and the annual figure for FY2025 was $55000.0, down 89.32%.
  • Change in Receivables for Q4 2025 was -$15000.0 at Upstream Bio, up from -$254000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for UPB hit a ceiling of $640000.0 in Q1 2024 and a floor of -$254000.0 in Q3 2025.
  • Median Change in Receivables over the past 3 years was -$15000.0 (2025), compared with a mean of $44777.8.
  • Peak annual rise in Change in Receivables hit 262.72% in 2025, while the deepest fall reached 361.86% in 2025.
  • Upstream Bio's Change in Receivables stood at -$167000.0 in 2023, then surged by 103.59% to $6000.0 in 2024, then tumbled by 350.0% to -$15000.0 in 2025.
  • The last three reported values for Change in Receivables were -$15000.0 (Q4 2025), -$254000.0 (Q3 2025), and $371000.0 (Q2 2025) per Business Quant data.